Entero Therapeutics (GRDX) P/E (2016 - 2026)
Entero Therapeutics (GRDX) P/E from Oct 11, 2016 to Jul 21, 2026. The TTM Entero Therapeutics (GRDX) P/E is -1.51. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Entero Therapeutics (GRDX)
| Year | P/E | Change |
|---|---|---|
| 2026 | -1.51 | -16.60% |
| 2025 | -1.81 | +877.01% |
| 2024 | -0.18 | -71.04% |
| 2023 | -0.64 | +544.03% |
| 2022 | -0.10 | -95.38% |
| 2021 | -2.15 | -86.92% |
| 2020 | -16.42 | +7.94% |
| 2019 | -15.21 | +8.71% |
| 2018 | -13.99 | -46.45% |
| 2017 | -26.13 | -70.71% |
| 2016 | -89.23 | N/A |
Comparison Entero Therapeutics (GRDX) P/E with competitors
Entero Therapeutics (GRDX) P/E is -1.51.